LitCovid-sample-Enju  

PMC:7205724 / 28043-29432 JSONTXT 18 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T2209 0-4 NN denotes Lack
T82418 5-7 IN denotes of
T17483 8-16 JJ denotes specific
T11435 17-27 NNS denotes treatments
T58860 28-31 IN denotes for
T97288 32-40 NN denotes COVID-19
T14954 41-44 CC denotes and
T67635 45-48 DT denotes the
T14560 49-53 RB denotes very
T29994 54-68 JJ denotes time-consuming
T54347 69-76 NN denotes process
T43425 77-79 IN denotes of
T40405 80-87 NN denotes vaccine
T65584 88-99 NN denotes development
T26632 100-104 VBP denotes lead
T87212 105-107 PRP denotes us
T4319 108-110 TO denotes to
T17398 111-116 VB denotes trust
T39922 117-128 JJ denotes traditional
T59832 129-136 NNS denotes notions
T79640 137-139 IN denotes of
T39982 140-152 NN denotes immunization
T68886 153-158 VBG denotes using
T59526 159-166 JJ denotes passive
T93112 167-175 NN denotes transfer
T2403 176-178 IN denotes of
T97514 179-186 JJ denotes humoral
T67166 187-195 NN denotes immunity
T8460 197-204 JJ denotes Passive
T78989 205-217 NN denotes immunization
T37380 218-221 MD denotes can
T3292 222-224 VB denotes be
T87394 225-229 VBN denotes done
T83285 230-235 VBG denotes using
T80590 236-242 NN denotes plasma
T40394 243-250 NN denotes therapy
T28898 251-254 CC denotes and
T56173 255-259 NN denotes IVIG
T89662 260-267 NN denotes therapy
T43126 269-275 NN denotes Plasma
T98086 276-280 IN denotes from
T4913 281-289 NNS denotes patients
T85558 290-299 VBN denotes recovered
T54139 300-304 IN denotes from
T65005 305-313 NN denotes COVID-19
T70575 314-318 WDT denotes that
T50076 319-327 VBZ denotes contains
T23714 328-338 NNS denotes antibodies
T54709 339-346 IN denotes against
T26763 347-356 NN denotes SARS-CoV2
T82790 357-360 VBZ denotes has
T72786 361-366 VBN denotes shown
T96449 367-376 JJ denotes promising
T61880 377-384 NNS denotes results
T36158 385-387 IN denotes in
T98710 388-396 NNS denotes patients
T52661 397-401 IN denotes with
T93981 402-408 JJ denotes severe
T61440 409-417 NN denotes COVID-19
T56097 419-423 RB denotes Also
T27399 423-424 -COMMA- denotes ,
T46672 425-433 NN denotes SARS-CoV
T4016 434-437 CC denotes and
T5488 438-447 NN denotes SARS-CoV2
T49089 448-451 VBP denotes are
T63728 452-459 RB denotes ideally
T58020 460-467 JJ denotes similar
T17353 468-470 IN denotes in
T77583 471-474 DT denotes the
T84845 475-484 NN denotes structure
T63353 485-488 CC denotes and
T19500 489-492 DT denotes the
T16312 493-497 NN denotes cell
T15071 498-503 NN denotes entry
T65845 504-512 NN denotes receptor
T64776 513-516 CC denotes and
T5365 517-525 NN denotes protease
T91360 527-534 NNS denotes Studies
T61175 535-539 VBP denotes show
T3464 540-544 IN denotes that
T71594 545-550 NN denotes serum
T59411 551-555 IN denotes from
T50943 556-568 JJ denotes convalescent
T99070 569-573 NN denotes SARS
T52714 574-582 NNS denotes patients
T30344 583-586 CC denotes and
T97752 587-592 NN denotes serum
T56749 593-597 IN denotes from
T81227 598-605 NNS denotes rabbits
T65088 606-615 VBN denotes immunized
T9531 616-620 IN denotes with
T3496 621-625 NNS denotes SARS
T18753 626-629 VBP denotes are
T56305 630-634 DT denotes both
T22390 635-639 JJ denotes able
T89303 640-642 TO denotes to
T72802 643-653 VB denotes neutralize
T57194 654-663 NN denotes SARS-CoV2
T63708 664-675 RB denotes efficiently
T61132 677-684 RB denotes However
T21857 684-685 -COMMA- denotes ,
T14229 686-691 NN denotes serum
T89468 692-696 IN denotes from
T75820 697-701 NNS denotes bats
T4213 702-711 VBN denotes immunized
T87498 712-716 IN denotes with
T5484 717-726 JJ denotes SARS-lice
T47898 727-738 NN denotes coronavirus
T5732 739-745 NN denotes SL-CoV
T45225 746-749 NN denotes Rp3
T42100 750-755 MD denotes could
T14407 756-759 RB denotes not
T21817 760-765 VB denotes exert
T34384 766-770 JJ denotes such
T15054 771-773 DT denotes an
T64476 774-780 NN denotes effect
T80575 782-784 PRP denotes It
T5249 785-787 VBZ denotes is
T88108 788-791 JJ denotes due
T14481 792-794 TO denotes to
T48691 795-796 DT denotes a
T43979 797-807 JJ denotes noticeable
T25730 808-814 NN denotes degree
T63462 815-817 IN denotes of
T72538 818-828 NN denotes difference
T22468 829-831 IN denotes in
T50331 832-835 DT denotes the
T61223 836-838 NN denotes S1
T8313 839-845 NN denotes domain
T42013 846-848 IN denotes in
T41693 849-852 DT denotes the
T41576 853-855 NN denotes S1
T33017 856-862 NN denotes domain
T6643 863-870 IN denotes between
T73200 871-874 DT denotes the
T38226 875-878 NN denotes bat
T96665 879-885 NN denotes SL-CoV
T68744 886-889 NN denotes Rp3
T25467 890-896 NN denotes strain
T80157 897-900 CC denotes and
T9673 901-910 NN denotes SARS-CoV2
T92096 912-913 DT denotes A
T21466 914-924 JJ denotes short-term
T18604 925-933 JJ denotes moderate
T45992 934-938 NN denotes dose
T31582 939-941 IN denotes of
T44685 942-946 NN denotes IVIG
T42097 947-955 VBN denotes combined
T36053 956-960 IN denotes with
T48662 961-974 NN denotes moderate-dose
T22507 975-977 IN denotes of
T9912 978-993 NNS denotes corticosteroids
T83835 994-999 MD denotes might
T7774 1000-1007 VB denotes improve
T16718 1008-1015 NN denotes patient
T30604 1016-1024 NNS denotes outcomes
T91513 1026-1033 NNS denotes Studies
T81529 1034-1038 VBP denotes show
T7530 1039-1043 IN denotes that
T31986 1044-1047 DT denotes the
T73402 1048-1053 JJ denotes viral
T42028 1054-1057 NN denotes RNA
T66238 1058-1060 IN denotes of
T77066 1061-1070 NN denotes SARS-CoV2
T7474 1071-1078 VBZ denotes reaches
T81899 1079-1082 PRP-DOLLAR- denotes its
T82598 1083-1087 NN denotes peak
T40173 1088-1094 IN denotes during
T31013 1095-1098 DT denotes the
T16396 1099-1104 JJ denotes first
T75325 1105-1109 NN denotes week
T4182 1110-1113 CC denotes and
T18300 1114-1118 RB denotes then
T56358 1119-1128 RB denotes gradually
T76094 1129-1138 VBZ denotes decreases
T20828 1139-1142 CC denotes and
T83224 1143-1147 IN denotes that
T96146 1148-1151 NN denotes IgG
T47796 1152-1155 CC denotes and
T69933 1156-1159 NN denotes IgM
T32800 1160-1165 VBP denotes begin
T67925 1166-1168 TO denotes to
T47586 1169-1173 VB denotes rise
T31692 1174-1178 IN denotes from
T7968 1179-1182 DT denotes the
T13466 1183-1187 JJ denotes 10th
T6862 1188-1191 NN denotes day
T3983 1192-1194 IN denotes so
T20802 1195-1199 IN denotes that
T89923 1200-1204 JJS denotes most
T68511 1205-1213 NNS denotes patients
T75930 1214-1218 VBP denotes have
T84637 1219-1229 JJ denotes anti-viral
T76069 1230-1240 NNS denotes antibodies
T50453 1241-1243 IN denotes by
T78621 1244-1247 DT denotes the
T91971 1248-1252 JJ denotes 14th
T55876 1253-1256 NN denotes day
T58337 1258-1265 JJ denotes Passive
T80315 1266-1278 NN denotes immunization
T58229 1279-1287 VBZ denotes protects
T77600 1288-1295 IN denotes against
T79174 1296-1303 NN denotes disease
T49092 1303-1304 -COMMA- denotes ,
T77811 1305-1308 CC denotes and
T60601 1309-1311 IN denotes so
T49810 1312-1314 PRP denotes it
T35724 1315-1321 MD denotes should
T59058 1322-1324 VB denotes be
T47054 1325-1337 VBN denotes administered
T78182 1338-1340 RB denotes as
T58224 1341-1346 RB denotes early
T10653 1347-1349 IN denotes as
T65232 1350-1358 JJ denotes possible
T7135 1359-1363 WRB denotes when
T74033 1364-1367 DT denotes the
T73325 1368-1375 NN denotes patient
T59206 1376-1378 VBZ denotes is
T72256 1379-1388 VBN denotes diagnosed
R10212 T80315 T58337 arg1Of immunization,Passive
R10231 T49810 T59058 arg1Of it,be
R10241 T98710 T36158 arg2Of patients,in
R10698 T65845 T64776 arg1Of receptor,and
R11155 T2209 T82418 arg1Of Lack,of
R12004 T7474 T40173 arg1Of reaches,during
R12080 T6862 T7968 arg1Of day,the
R12583 T14229 T42100 arg1Of serum,could
R13185 T72256 T59206 arg2Of diagnosed,is
R13443 T72786 T82790 arg2Of shown,has
R14139 T14954 T26632 arg1Of and,lead
R14356 T75820 T89468 arg2Of bats,from
R14380 T54347 T67635 arg1Of process,the
R15297 T78989 T3292 arg1Of immunization,be
R15830 T47586 T32800 arg2Of rise,begin
R16377 T54347 T43425 arg1Of process,of
R18503 T11435 T82418 arg2Of treatments,of
R18836 T45992 T92096 arg1Of dose,A
R19355 T71594 T59411 arg1Of serum,from
R1991 T75325 T31013 arg1Of week,the
R20107 T21817 T61132 arg1Of exert,However
R20867 T80157 T73200 arg1Of and,the
R21122 T87212 T26632 arg2Of us,lead
R22102 T47054 T59058 arg2Of administered,be
R22208 T42028 T66238 arg1Of RNA,of
R22660 T64776 T16312 arg1Of and,cell
R23204 T65005 T50076 arg1Of COVID-19,contains
R24045 T84845 T77583 arg1Of structure,the
R24478 T47054 T7135 arg1Of administered,when
R24570 T89662 T56173 arg1Of therapy,IVIG
R24947 T42028 T7474 arg1Of RNA,reaches
R24971 T25730 T22468 arg1Of degree,in
R25355 T46672 T4016 arg1Of SARS-CoV,and
R25456 T32800 T83224 arg2Of begin,that
R25978 T49089 T56097 arg1Of are,Also
R26081 T29994 T14560 arg1Of time-consuming,very
R26476 T61880 T72786 arg2Of results,shown
R26632 T48662 T22507 arg1Of moderate-dose,of
R26862 T45992 T18604 arg1Of dose,moderate
R27176 T58020 T17353 arg1Of similar,in
R27770 T75325 T40173 arg2Of week,during
R27833 T59832 T39922 arg1Of notions,traditional
R28653 T47586 T67925 arg1Of rise,to
R29470 T47796 T47586 arg1Of and,rise
R30321 T97752 T30344 arg2Of serum,and
R30604 T26763 T54709 arg2Of SARS-CoV2,against
R31512 T17398 T26632 arg3Of trust,lead
R32703 T3983 T20802 arg1Of so,that
R32754 T64776 T19500 arg1Of and,the
R33107 T33017 T42013 arg2Of domain,in
R33115 T93112 T59526 arg1Of transfer,passive
R33132 T55876 T91971 arg1Of day,14th
R33152 T71594 T30344 arg1Of serum,and
R33460 T54347 T14954 arg2Of process,and
R33698 T47796 T32800 arg1Of and,begin
R33815 T7474 T4182 arg1Of reaches,and
R34099 T58224 T78182 arg1Of early,as
R3415 T33017 T41576 arg1Of domain,S1
R34870 T63353 T17353 arg2Of and,in
R36008 T97752 T56749 arg1Of serum,from
R36046 T4913 T85558 arg2Of patients,recovered
R36058 T59832 T79640 arg1Of notions,of
R36595 T55876 T78621 arg1Of day,the
R37168 T64476 T34384 arg1Of effect,such
R37865 T80315 T58229 arg1Of immunization,protects
R39436 T23714 T50076 arg2Of antibodies,contains
R40089 T85558 T54139 arg1Of recovered,from
R40363 T45225 T5484 arg1Of Rp3,SARS-lice
R41066 T82598 T81899 arg1Of peak,its
R41169 T20828 T81529 arg2Of and,show
R4189 T76094 T18300 arg1Of decreases,then
R42193 T68511 T75930 arg1Of patients,have
R42253 T45225 T5732 arg1Of Rp3,SL-CoV
R4231 T52714 T50943 arg1Of patients,convalescent
R42624 T30344 T72802 arg1Of and,neutralize
R44466 T72802 T22390 arg2Of neutralize,able
R44540 T75325 T16396 arg1Of week,first
R45413 T58229 T77600 arg1Of protects,against
R45491 T42028 T73402 arg1Of RNA,viral
R45855 T89662 T28898 arg2Of therapy,and
R46683 T28898 T83285 arg2Of and,using
R4750 T93112 T68886 arg2Of transfer,using
R47705 T77066 T66238 arg2Of SARS-CoV2,of
R48219 T6862 T31692 arg2Of day,from
R48539 T23714 T54709 arg1Of antibodies,against
R48932 T14481 T5249 arg2Of to,is
R49189 T80575 T14481 arg1Of It,to
R49757 T75930 T3983 arg2Of have,so
R49902 T75930 T50453 arg1Of have,by
R50736 T2209 T14954 arg1Of Lack,and
R51321 T61440 T52661 arg2Of COVID-19,with
R51383 T11435 T17483 arg1Of treatments,specific
R51784 T65005 T70575 arg1Of COVID-19,that
R52004 T45225 T47898 arg1Of Rp3,coronavirus
R52856 T49810 T35724 arg1Of it,should
R53389 T81227 T65088 arg2Of rabbits,immunized
R54690 T93112 T2403 arg1Of transfer,of
R55027 T45992 T31582 arg1Of dose,of
R55206 T6862 T13466 arg1Of day,10th
R55295 T14229 T21817 arg1Of serum,exert
R55476 T4913 T98086 arg2Of patients,from
R5555 T4182 T7530 arg1Of and,that
R55726 T96146 T47796 arg1Of IgG,and
R5580 T25730 T48691 arg1Of degree,a
R55870 T59832 T68886 arg1Of notions,using
R5589 T45992 T21466 arg1Of dose,short-term
R55984 T80157 T96665 arg1Of and,SL-CoV
R56468 T4016 T49089 arg1Of and,are
R56955 T68511 T89923 arg1Of patients,most
R58970 T67166 T97514 arg1Of immunity,humoral
R59166 T14481 T88108 arg1Of to,due
R59273 T21817 T42100 arg2Of exert,could
R59603 T49810 T47054 arg2Of it,administered
R60276 T8313 T61223 arg1Of domain,S1
R60347 T30604 T7774 arg2Of outcomes,improve
R60813 T45992 T7774 arg1Of dose,improve
R61124 T17398 T4319 arg1Of trust,to
R61660 T65005 T54139 arg2Of COVID-19,from
R61697 T64476 T21817 arg2Of effect,exert
R62451 T8313 T22468 arg2Of domain,in
R62464 T78989 T8460 arg1Of immunization,Passive
R63178 T45992 T83835 arg1Of dose,might
R63553 T47054 T77811 arg2Of administered,and
R63810 T79174 T77600 arg2Of disease,against
R65636 T87394 T3292 arg2Of done,be
R65883 T72802 T89303 arg1Of neutralize,to
R6618 T73325 T72256 arg2Of patient,diagnosed
R66400 T58020 T49089 arg2Of similar,are
R66967 T9912 T22507 arg2Of corticosteroids,of
R67187 T72256 T7135 arg2Of diagnosed,when
R67339 T65584 T40405 arg1Of development,vaccine
R6815 T47054 T60601 arg1Of administered,so
R68274 T83224 T20828 arg2Of that,and
R68311 T40394 T80590 arg1Of therapy,plasma
R68462 T52714 T99070 arg1Of patients,SARS
R68691 T44685 T42097 arg2Of IVIG,combined
R69010 T78989 T37380 arg1Of immunization,can
R69846 T5488 T4016 arg2Of SARS-CoV2,and
R6989 T76094 T4182 arg2Of decreases,and
R7008 T64476 T15054 arg1Of effect,an
R71243 T65088 T9531 arg1Of immunized,with
R71258 T73325 T59206 arg1Of patient,is
R71444 T97288 T58860 arg2Of COVID-19,for
R72430 T76094 T56358 arg1Of decreases,gradually
R7289 T77811 T49092 arg1Of and,","
R73057 T33017 T41693 arg1Of domain,the
R73284 T43126 T72786 arg1Of Plasma,shown
R73891 T21817 T14407 arg1Of exert,not
R74536 T87212 T17398 arg1Of us,trust
R75896 T64776 T63353 arg2Of and,and
R75925 T49089 T27399 arg1Of are,","
R76565 T65232 T10653 arg2Of possible,as
R76662 T9673 T80157 arg2Of SARS-CoV2,and
R76744 T80157 T38226 arg1Of and,bat
R76775 T4016 T58020 arg1Of and,similar
R76787 T25730 T63462 arg1Of degree,of
R76838 T4182 T20828 arg1Of and,and
R76856 T47054 T58224 arg1Of administered,early
R77343 T48662 T36053 arg2Of moderate-dose,with
R77927 T59832 T17398 arg2Of notions,trust
R78223 T87394 T83285 modOf done,using
R78514 T44685 T31582 arg2Of IVIG,of
R79733 T18753 T61175 arg2Of are,show
R80156 T64776 T15071 arg1Of and,entry
R80184 T69933 T47796 arg2Of IgM,and
R80485 T43126 T82790 arg1Of Plasma,has
R80683 T4213 T87498 arg1Of immunized,with
R81229 T76069 T84637 arg1Of antibodies,anti-viral
R81252 T43126 T98086 arg1Of Plasma,from
R8259 T25467 T80157 arg1Of strain,and
R83662 T25730 T14481 arg2Of degree,to
R83757 T30604 T16718 arg1Of outcomes,patient
R8377 T76069 T75930 arg2Of antibodies,have
R84281 T80575 T5249 arg1Of It,is
R84283 T45225 T87498 arg2Of Rp3,with
R84947 T91360 T61175 arg1Of Studies,show
R85256 T8313 T50331 arg1Of domain,the
R85443 T49089 T63728 arg1Of are,ideally
R85714 T22390 T18753 arg2Of able,are
R85975 T30344 T22390 arg1Of and,able
R86230 T65584 T43425 arg2Of development,of
R86414 T39982 T79640 arg2Of immunization,of
R87111 T72538 T63462 arg2Of difference,of
R8803 T33017 T6643 arg1Of domain,between
R88068 T57194 T72802 arg2Of SARS-CoV2,neutralize
R8823 T47054 T35724 arg2Of administered,should
R8839 T87394 T37380 arg2Of done,can
R88823 T47586 T31692 arg1Of rise,from
R89002 T18753 T3464 arg1Of are,that
R89083 T18753 T56305 arg1Of are,both
R89244 T84845 T63353 arg1Of structure,and
R89296 T14229 T89468 arg1Of serum,from
R90227 T80157 T68744 arg1Of and,Rp3
R90414 T11435 T58860 arg1Of treatments,for
R90438 T75820 T4213 arg2Of bats,immunized
R9144 T30344 T18753 arg1Of and,are
R91830 T42028 T76094 arg1Of RNA,decreases
R9189 T61880 T96449 arg1Of results,promising
R92578 T58224 T10653 arg1Of early,as
R92880 T82598 T7474 arg2Of peak,reaches
R93364 T78989 T87394 arg2Of immunization,done
R94308 T61440 T93981 arg1Of COVID-19,severe
R94383 T91513 T81529 arg1Of Studies,show
R94949 T7774 T83835 arg2Of improve,might
R9501 T80157 T6643 arg2Of and,between
R95128 T98710 T52661 arg1Of patients,with
R96077 T55876 T50453 arg2Of day,by
R96158 T42028 T31986 arg1Of RNA,the
R96440 T47586 T3983 arg1Of rise,so
R96809 T21817 T21857 arg1Of exert,","
R96826 T42097 T36053 arg1Of combined,with
R97110 T54347 T29994 arg1Of process,time-consuming
R97705 T67166 T2403 arg2Of immunity,of
R98291 T73325 T74033 arg1Of patient,the
R98416 T72802 T63708 arg1Of neutralize,efficiently
R98878 T8313 T42013 arg1Of domain,in
R98915 T25730 T43979 arg1Of degree,noticeable
R98943 T81227 T56749 arg2Of rabbits,from
R99006 T5365 T64776 arg2Of protease,and
R99280 T58229 T77811 arg1Of protects,and
R99410 T52714 T59411 arg2Of patients,from
R99439 T3496 T9531 arg2Of SARS,with
R99456 T72786 T36158 arg1Of shown,in
R99492 T40394 T28898 arg1Of therapy,and